Avalo Therapeutics, Inc. (AVTX)

Healthcare · Biotechnology · NASDAQ

Avalo Therapeutics, Inc. (AVTX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.06B and a free-cash-flow yield of -19.4%. Over the most recent reported fiscal year, revenue declined 86.6%.

Market cap	$1.06B
Trailing P/E	—
FCF yield	-19.4%
Revenue growth (YoY)	-86.6%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live AVTX data on Nama Insights →